Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 605-607, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brody, J. P.
Right arrow Articles by Wills, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brody, J. P.
Right arrow Articles by Wills, M. R.

Clinical Chemistry, Vol 27, 605-607, Copyright © 1981 by American Association for Clinical Chemistry

Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma

JP Brody, J Savory, BC Sturgill, MR Lehman and MR Wills

Serum prostatic acid phosphatase concentration was measured with two commercially available radioimmunoassay kits. Results were compared with histological evidence of prostatic adenocarcinoma obtained at autopsy in 33 patients. The serum assay did not differentiate significantly (p greater than 0.1) between patients with adenocarcinoma and those without. We conclude that the test, at least as performed by use of these kits, is of little value in the detection of occult disease.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.